Whether pursuing high-tech solutions, tapping into natural elements, or doubling down on smaller building sizes, the future of healthcare facilities design boils down to improving patient access and nurturing employee retention. The post Facilities Built for the Future: 3 Healthcare Design Trends Emerging in 2025 and Beyond appeared first on MedCity News.
Enhertu is currently approved as a second-line treatment for HER2-positive metastatic breast cancer. The new results for the AstraZeneca and Daiichi Sankyo drug in the first-line setting are important because many patients do not live long enough to receive a second-line cancer therapy. The post AstraZeneca & Daiichi Sankyo’s Enhertu Posts Positive Data as First-Line…
That is the question asked in a new paper by Enright, et al. (2025). The authors use the Tufts Medical Center Specialty Drug Evidence and Coverage (SPEC) database current as of August 2023. This database contains publicly available specialty pharmacy coverage decisions as issued by 18 large US commercial health plans, which—collectively—cover 200m people (i.e.,…
A western New York health insurance provider for seniors and the CEO of its medical analytics arm have agreed to pay a total of up to $100 million to settle Justice Department allegations of fraudulent billing for health conditions that were exaggerated or didn’t exist. Independent Health Association of Buffalo, which operates two Medicare Advantage…
Las tasas de tos convulsa, también conocida como tos ferina o pertussis, están aumentando en Texas, Florida, California, Oregon y otras localidades y estados del país. Según entrevistas con funcionarios de salud estatales y federales, los brotes son impulsados por la caída en las tasas de vacunación, la disminución de la inmunidad y los retrasos…
In the future, healthcare AI startups that offer multimodal models may have an easier time raising venture capital than healthcare AI companies that don’t, according to Morgan Cheatham, vice president at Bessemer Venture Partners. The post How One Investor Views the Future of Healthcare AI appeared first on MedCity News.
Former President Donald Trump’s election victory and looming return to the White House will likely bring changes that scale back the nation’s public health insurance programs — increasing the uninsured rate, while imposing new barriers to abortion and other reproductive care. The reverberations will be felt far beyond Washington, D.C., and could include an erosion…
CMS recently issued a statement saying that it’s continuing the Medicare Drug Price Negotiation Program but is leaving the door open for potential changes. Experts weighed in on what changes could be made and what changes they would like to see. The post Could the Trump Administration Change the Medicare Drug Price Negotiation Program? appeared…
This brief analyzes the Medicare Part D stand-alone prescription drug plan (PDP) market for 2027. The analysis shows that there will be a modest reduction in the number of PDPs for 2027, along with modest premium increases less than $10 per month for many enrollees, but much larger monthly premium increases of $50 or more…
Following the Trump administration’s warning last month that using acetaminophen – the active ingredient in Tylenol – during pregnancy can increase the risk of autism in children, very few (4%) adults say the claim about a causal relationship is “definitely true,” a new KFF Tracking Poll on Health Information and Trust finds.